Phase Ib Study of Berzosertib and Cisplatin in Patients With Advanced Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer
NPJ Breast Cancer 2022 Apr 07;8(1)45, ML Telli, SM Tolaney, GI Shapiro, M Middleton, SR Lord, HT Arkenau, A Tutt, V Abramson, E Dean, TC Haddad, R Wesolowski, J Ferrer-Playan, T Goddemeier, T Grombacher, J Dong, P Fleuranceau-Morel, I Diaz-Padilla, R PlummerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.